Avero expands its COVID-19 testing lineup

LabPulse.com staff writers
Aug 25, 2020
2020 08 25 20 54 0512 Test Tubes Rd Lab 400

Avero Diagnostics added the Roche Elecsys anti-SARS-CoV-2 antibody test to its COVID-19 testing portfolio. The serological test is available now and complements Avero's existing COVID-19 molecular testing program.

The Roche Elecsys test uses a blood sample to provide qualitative detection of high-affinity antibodies to SARS-CoV-2, identifying those with adaptive immune responses to the virus.

Latest in COVID-19
Long Covid Word Cloud Social
Quest launches long-COVID testing panels for consumers
March 22, 2023
Business Financial Stock Drop Social
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
March 21, 2023
Sars Co V 2 Spike Coronavirus Social
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
March 20, 2023
Fda Button Social
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
March 14, 2023
Related Stories
2020 06 17 20 35 0417 Covid 19 Antibody 400
COVID-19
Study finds SARS-CoV-2 antibody kits have varying accuracy
2019 08 09 22 20 6739 Beckman Coulter Aacc 2019 400
Validation
Beckman Coulter releases COVID-19 antibody test
2020 08 24 16 51 7799 Covid 19 Data Ai Information 400
Health Topics
Data-sharing platform could help planning for future pandemics
2020 07 24 17 07 6755 Globe Flags 400
Molecular Diagnostics
A look at how COVID-19 testing varies by world region
More in COVID-19
Quest launches long-COVID testing panels for consumers
The panels could be used by any of the millions of Americans that still suffer from lingering COVID-19 side effects, Quest said.
March 22, 2023
Long Covid Word Cloud Social
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
The firm recorded an accounting impairment in Q4 for excess manufacturing and inventory related to the scale-up during peak COVID-19 testing demand and the decision to pause commercialization of its Amira COVID-19 test.
March 21, 2023
Business Financial Stock Drop Social
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
People who recover from SARS-CoV-2 infection and then get vaccinated are more protected than people who are unvaccinated, the researchers added.
March 20, 2023
Sars Co V 2 Spike Coronavirus Social
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Specifically, the warning states that reports of adverse events after use of the vaccine under emergency use authorization (EUA) suggest increased risks of myocarditis and pericarditis, particularly from zero through seven days following vaccination.
March 14, 2023
Fda Button Social
Chicago man indicted for COVID-19 testing fraud
A Chicago lab that he co-owned obtained more then $83 million from the HRSA Uninsured Program as payment for COVID-19 tests purportedly performed by the laboratory, a U.S. Attorney's Office said.
March 14, 2023
Gavel Resized
Virufy nabs BARDA contract to develop cough- and speech-based COVID-19 detection technology
The project supports the firm’s aim to research and develop COVID-19 screening tools using artificial intelligence (AI)/machine learning (ML) technology.
March 8, 2023
Covid 19 Spread Usa Social
Most Popular
Quest launches long-COVID testing panels for consumers
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Patients prefer immediate test results, even when the news is bad
More in COVID-19
COVID-19 leads to increased chest pain long after infection
In an ongoing effort to quantify long COVID’s impacts, nearly 150,000 patients were studied for cardiovascular symptoms following a COVID-19 infection.
March 6, 2023
Chest Heart Pain Social
Artificial intelligence tool identifies current drugs for future pandemics
Researchers have created an algorithmic tool that calculates how to effectively repurpose current drugs to combat COVID-19 and future pandemics.
March 6, 2023
Covid 19 Pill Social
COVID-19 vaccine development: Public funding yielded private profits
A BMJ study calculated U.S. public investments in pre-pandemic COVID-19 vaccine development and recommended policy reforms to maximize public health benefits.
March 1, 2023
Covid 19 Vaccine Distribution Transport Social
Collaborative research helps long-COVID patients recover
An NIH initiative called Researching COVID to Enhance Recovery (RECOVER) joins patients with researchers to better understand and treat long COVID.
March 3, 2023
Long Covid Brain Graphic Social
Immune-response test in study detects COVID-19 with near-perfect accuracy
A test that monitors the body’s molecular response to the SARS‑CoV‑2 virus can diagnose even asymptomatic patients with near-perfect accuracy, the researchers said.
March 1, 2023
Coronavirus Covid Blue Social
NanoSpot.ai launches AI-based SARS-CoV-2 antibody test
The test uses an agglutination-based method combined with an artificial intelligence (AI)-enabled mobile application to deliver semi-quantitative antibody test results at the point of care.
February 28, 2023
Covid 19 Antibody Social
Page 1 of 29
Next Page